ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00BYZK4776
Stock Name / FundiShares Healthcare Innovation UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerDRDR(GBX) LSE
ETF Ticker2B78(EUR) F
ETF Ticker2B78.DE(EUR) CXE
ETF TickerDRDR.LS(GBX) CXE
ETF TickerHEAL.AS(EUR) CXE
ETF TickerHEAL.LS(USD) CXE
ETF TickerHEALz(USD) CXE
ETF TickerHEAL(EUR) ETF Plus
ETF TickerDRDR.L(GBP) LSE

Holdings detail for ATRC

Stock NameAtriCure Inc
TickerATRC(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS04963C2098

Show aggregate ATRC holdings

News associated with ATRC

AtriCure, Inc. (NASDAQ:ATRC) Receives Average Rating of “Buy” from Brokerages
AtriCure, Inc. (NASDAQ:ATRC – Get Free Report) has been given a consensus recommendation of “Buy” by the nine brokerages that are covering the stock, MarketBeat Ratings reports. Nine analysts have rated the stock with a buy rating. The average 1 year price target among analysts that have issued ratings on the stock in the last […] - 2025-08-22 02:26:44
AtriCure, Inc. (NASDAQ:ATRC) Short Interest Up 46.1% in July
AtriCure, Inc. (NASDAQ:ATRC – Get Free Report) saw a significant increase in short interest during the month of July. As of July 31st, there was short interest totaling 2,220,000 shares, anincreaseof46.1% from the July 15th total of 1,520,000 shares. Based on an average daily volume of 546,100 shares, the short-interest ratio is presently 4.1 days. […] - 2025-08-21 05:28:44
XTX Topco Ltd Makes New $526,000 Investment in AtriCure, Inc. (NASDAQ:ATRC)
XTX Topco Ltd purchased a new position in shares of AtriCure, Inc. (NASDAQ:ATRC – Free Report) during the first quarter, Holdings Channel reports. The firm purchased 16,301 shares of the medical device company’s stock, valued at approximately $526,000. A number of other hedge funds also recently bought and sold shares of the business. Hood River […] - 2025-08-07 05:01:01
Mackenzie Financial Corp Increases Position in AtriCure, Inc. (NASDAQ:ATRC)
Mackenzie Financial Corp lifted its holdings in shares of AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 91.6% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 29,143 shares of the medical device company’s stock after acquiring an additional 13,929 shares during the quarter. Mackenzie Financial […] - 2025-08-06 05:07:47
AtriCure (NASDAQ:ATRC) Shares Gap Up on Strong Earnings
AtriCure, Inc. (NASDAQ:ATRC – Get Free Report)’s stock price gapped up prior to trading on Wednesday after the company announced better than expected quarterly earnings. The stock had previously closed at $31.73, but opened at $37.70. AtriCure shares last traded at $37.03, with a volume of 594,302 shares traded. The medical device company reported ($0.02) […] - 2025-08-01 02:07:09
Allianz Asset Management GmbH Has $3.96 Million Holdings in AtriCure, Inc. (NASDAQ:ATRC)
Allianz Asset Management GmbH lifted its holdings in AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 22.8% during the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 122,858 shares of the medical device company’s stock after acquiring an additional 22,838 shares during the period. Allianz Asset Management GmbH owned […] - 2025-07-29 04:44:56
AtriCure, Inc. (NASDAQ:ATRC) Receives Average Recommendation of “Buy” from Analysts
AtriCure, Inc. (NASDAQ:ATRC – Get Free Report) has been given a consensus recommendation of “Buy” by the nine ratings firms that are covering the stock, Marketbeat Ratings reports. Nine research analysts have rated the stock with a buy recommendation. The average 12 month price target among brokerages that have updated their coverage on the stock […] - 2025-07-28 03:06:51
Mackenzie Financial Corp Takes Position in AtriCure, Inc. (NASDAQ:ATRC)
Mackenzie Financial Corp acquired a new position in AtriCure, Inc. (NASDAQ:ATRC – Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 15,214 shares of the medical device company’s stock, valued at approximately $465,000. Other institutional investors and hedge funds have also […] - 2025-06-04 05:16:59
AtriCure (NASDAQ:ATRC) Stock Rating Lowered by Wall Street Zen
Wall Street Zen cut shares of AtriCure (NASDAQ:ATRC – Free Report) from a buy rating to a hold rating in a research report released on Sunday morning. A number of other analysts also recently weighed in on ATRC. Piper Sandler upped their target price on shares of AtriCure from $40.00 to $50.00 and gave the […] - 2025-06-02 04:26:45
AtriCure, Inc. (NASDAQ:ATRC) Shares Sold by Squarepoint Ops LLC
Squarepoint Ops LLC cut its holdings in AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 64.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 55,472 shares of the medical device company’s stock after selling 101,207 shares during the […] - 2025-05-30 05:35:00
State of Wyoming Acquires 446 Shares of AtriCure, Inc. (NASDAQ:ATRC)
State of Wyoming boosted its position in shares of AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 21.9% in the 4th quarter, HoldingsChannel reports. The firm owned 2,481 shares of the medical device company’s stock after buying an additional 446 shares during the period. State of Wyoming’s holdings in AtriCure were worth $76,000 at the end […] - 2025-05-29 05:08:55
ProShare Advisors LLC Increases Stock Holdings in AtriCure, Inc. (NASDAQ:ATRC)
ProShare Advisors LLC grew its stake in AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 49.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 13,330 shares of the medical device company’s stock after purchasing an additional 4,385 shares during the quarter. ProShare […] - 2025-05-28 05:13:03
Man Group plc Invests $745,000 in AtriCure, Inc. (NASDAQ:ATRC)
Man Group plc purchased a new position in AtriCure, Inc. (NASDAQ:ATRC – Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 24,368 shares of the medical device company’s stock, valued at approximately $745,000. Other institutional investors and hedge funds […] - 2025-05-26 05:01:05
AtriCure (NASDAQ:ATRC) Stock Rating Upgraded by Wall Street Zen
AtriCure (NASDAQ:ATRC – Get Free Report) was upgraded by research analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a report released on Saturday. A number of other analysts have also commented on ATRC. Stifel Nicolaus boosted their price objective on shares of AtriCure from $36.00 to $48.00 and gave […] - 2025-05-26 02:12:50
ATRC Crosses Below Key Moving Average Level
In trading on Friday, shares of AtriCure Inc (Symbol: ATRC) crossed below their 200 day moving average of $32.37, changing hands as low as $31.95 per share. AtriCure Inc shares are currently trading down about 0.8% on the day. The chart below shows the one year performance of - 2025-05-23 12:36:54
Nuveen Asset Management LLC Sells 149,584 Shares of AtriCure, Inc. (NASDAQ:ATRC)
Nuveen Asset Management LLC decreased its position in AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 12.6% during the fourth quarter, HoldingsChannel.com reports. The firm owned 1,037,348 shares of the medical device company’s stock after selling 149,584 shares during the quarter. Nuveen Asset Management LLC’s holdings in AtriCure were worth $31,701,000 as of its most recent […] - 2025-05-22 05:58:59
BNP Paribas Financial Markets Has $2.97 Million Holdings in AtriCure, Inc. (NASDAQ:ATRC)
BNP Paribas Financial Markets lifted its position in shares of AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 676.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 97,310 shares of the medical device company’s stock after buying an additional 84,776 […] - 2025-05-16 06:02:57
Northern Trust Corp Increases Holdings in AtriCure, Inc. (NASDAQ:ATRC)
Northern Trust Corp grew its holdings in AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 11.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 483,607 shares of the medical device company’s stock after purchasing an additional 50,153 shares during the […] - 2025-05-16 04:38:56
Dimensional Fund Advisors LP Raises Position in AtriCure, Inc. (NASDAQ:ATRC)
Dimensional Fund Advisors LP increased its stake in shares of AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 24.1% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 700,212 shares of the medical device company’s stock after acquiring an additional 136,015 shares during the quarter. Dimensional Fund Advisors LP’s holdings in AtriCure were worth $21,398,000 […] - 2025-05-08 04:45:00
Barclays PLC Has $2.64 Million Holdings in AtriCure, Inc. (NASDAQ:ATRC)
Barclays PLC trimmed its holdings in AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 33.1% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 86,541 shares of the medical device company’s stock after selling 42,724 shares during the quarter. Barclays PLC’s holdings in AtriCure were worth […] - 2025-05-01 05:14:58
AtriCure (NASDAQ:ATRC) Trading Up 4.9% After Better-Than-Expected Earnings
AtriCure, Inc. (NASDAQ:ATRC – Get Free Report)’s share price traded up 4.9% on Tuesday following a stronger than expected earnings report. The company traded as high as $35.19 and last traded at $35.31. 373,568 shares were traded during mid-day trading, a decline of 43% from the average session volume of 654,896 shares. The stock had […] - 2025-05-01 02:40:58
Envestnet Asset Management Inc. Cuts Position in AtriCure, Inc. (NASDAQ:ATRC)
Envestnet Asset Management Inc. decreased its stake in AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 4.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 46,086 shares of the medical device company’s stock after selling 2,104 shares during the period. Envestnet Asset Management […] - 2025-04-30 04:42:56
Raymond James Financial Inc. Acquires Shares of 121,591 AtriCure, Inc. (NASDAQ:ATRC)
Raymond James Financial Inc. acquired a new stake in shares of AtriCure, Inc. (NASDAQ:ATRC – Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 121,591 shares of the medical device company’s stock, valued at approximately $3,716,000. Several other hedge […] - 2025-04-27 06:26:45
AtriCure (NASDAQ:ATRC) and KORU Medical Systems (NASDAQ:KRMD) Financial Survey
AtriCure (NASDAQ:ATRC – Get Free Report) and KORU Medical Systems (NASDAQ:KRMD – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, earnings, valuation, profitability, risk and dividends. Valuation and Earnings This table compares AtriCure […] - 2025-04-22 02:50:55
Townsquare Capital LLC Decreases Stake in AtriCure, Inc. (NASDAQ:ATRC)
Townsquare Capital LLC decreased its holdings in AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 4.7% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 16,138 shares of the medical device company’s stock after selling 789 shares during the period. Townsquare Capital LLC’s holdings in AtriCure were worth $493,000 […] - 2025-04-21 05:26:42
JPMorgan Chase & Co. Buys 110,039 Shares of AtriCure, Inc. (NASDAQ:ATRC)
JPMorgan Chase & Co. increased its stake in shares of AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 43.1% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 365,183 shares of the medical device company’s stock after acquiring an additional 110,039 shares during the quarter. JPMorgan Chase & Co.’s holdings in AtriCure were worth $11,160,000 […] - 2025-04-14 04:39:04
Corebridge Financial Inc. Reduces Holdings in AtriCure, Inc. (NASDAQ:ATRC)
Corebridge Financial Inc. lowered its stake in shares of AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 7.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 23,535 shares of the medical device company’s stock after selling 1,776 shares during the quarter. Corebridge Financial Inc.’s […] - 2025-04-07 04:32:51
Analysts Set AtriCure, Inc. (NASDAQ:ATRC) Target Price at $51.56
Shares of AtriCure, Inc. (NASDAQ:ATRC – Get Free Report) have earned an average recommendation of “Buy” from the nine analysts that are currently covering the firm, MarketBeat.com reports. Nine investment analysts have rated the stock with a buy rating. The average 1-year price objective among brokers that have issued ratings on the stock in the […] - 2025-03-28 04:56:46
Needham & Company LLC Reaffirms “Buy” Rating for AtriCure (NASDAQ:ATRC)
Needham & Company LLC reaffirmed their buy rating on shares of AtriCure (NASDAQ:ATRC – Free Report) in a research report sent to investors on Friday,Benzinga reports. They currently have a $51.00 price target on the medical device company’s stock. Several other analysts also recently commented on ATRC. JMP Securities reaffirmed a “market outperform” rating and […] - 2025-03-24 04:34:46
Analysts See 32% Gains Ahead For The Holdings of ESML
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-03-12 09:42:28

iShares Healthcare Innovation UCITS ETF USD (Acc) ATRC holdings

DateNumber of ATRC Shares HeldBase Market Value of ATRC SharesLocal Market Value of ATRC SharesChange in ATRC Shares HeldChange in ATRC Base ValueCurrent Price per ATRC Share HeldPrevious Price per ATRC Share Held
2025-11-27 (Thursday)60,185USD 2,168,466USD 2,168,4660USD 0 USD 36.03 USD 36.03
2025-11-26 (Wednesday)60,185USD 2,168,466ATRC holding decreased by -147453USD 2,168,4660USD -147,453 USD 36.03 USD 38.48
2025-11-25 (Tuesday)60,185USD 2,315,919ATRC holding increased by 44537USD 2,315,9190USD 44,537 USD 38.48 USD 37.74
2025-11-24 (Monday)60,185USD 2,271,382ATRC holding increased by 94491USD 2,271,3820USD 94,491 USD 37.74 USD 36.17
2025-11-21 (Friday)60,185USD 2,176,891ATRC holding increased by 175740USD 2,176,8910USD 175,740 USD 36.17 USD 33.25
2025-11-20 (Thursday)60,185USD 2,001,151ATRC holding decreased by -55972USD 2,001,1510USD -55,972 USD 33.25 USD 34.18
2025-11-19 (Wednesday)60,185USD 2,057,123ATRC holding increased by 61388USD 2,057,1230USD 61,388 USD 34.18 USD 33.16
2025-11-18 (Tuesday)60,185USD 1,995,735ATRC holding increased by 2408USD 1,995,7350USD 2,408 USD 33.16 USD 33.12
2025-11-17 (Monday)60,185USD 1,993,327ATRC holding increased by 13240USD 1,993,3270USD 13,240 USD 33.12 USD 32.9
2025-11-14 (Friday)60,185ATRC holding decreased by -550USD 1,980,087ATRC holding increased by 54180USD 1,980,087-550USD 54,180 USD 32.9 USD 31.71
2025-11-13 (Thursday)60,735USD 1,925,907ATRC holding decreased by -81992USD 1,925,9070USD -81,992 USD 31.71 USD 33.06
2025-11-12 (Wednesday)60,735USD 2,007,899ATRC holding increased by 12147USD 2,007,8990USD 12,147 USD 33.06 USD 32.86
2025-11-11 (Tuesday)60,735USD 1,995,752ATRC holding increased by 52839USD 1,995,7520USD 52,839 USD 32.86 USD 31.99
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of ATRC by Blackrock for IE00BYZK4776

Show aggregate share trades of ATRC

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-14SELL-55032.95031.220 31.393USD -17,266 34.44 Profit of 1,677 on sale
2025-10-24SELL-51637.54037.830 37.801USD -19,505 34.50 Loss of -1,705 on sale
2025-09-11BUY25937.56037.660 37.650USD 9,751 34.32
2025-07-08SELL-25831.63032.090 32.044USD -8,267 34.50 Profit of 635 on sale
2025-06-24SELL-26032.74032.800 32.794USD -8,526 34.66 Profit of 484 on sale
2025-06-23SELL-26031.90032.020 32.008USD -8,322 34.68 Profit of 694 on sale
2025-06-20BUY2,26831.40031.940 31.886USD 72,317 34.70
2025-06-11SELL-25033.02034.490 34.343USD -8,586 34.84 Profit of 123 on sale
2025-05-30SELL-25034.57034.760 34.741USD -8,685 34.86 Profit of 30 on sale
2025-05-21BUY25033.26034.220 34.124USD 8,531 34.96
2025-05-14SELL-1,49432.25032.580 32.547USD -48,625 35.04 Profit of 3,719 on sale
2025-04-30SELL-24929.91031.980 31.773USD -7,911 35.50 Profit of 927 on sale
2025-04-28SELL-24933.67034.090 34.048USD -8,478 35.52 Profit of 367 on sale
2025-04-25SELL-24933.40033.570 33.553USD -8,355 35.55 Profit of 496 on sale
2025-04-11SELL-1,50632.07032.590 32.538USD -49,002 35.83 Profit of 4,958 on sale
2025-04-08SELL-75030.61033.460 33.175USD -24,881 35.97 Profit of 2,096 on sale
2025-04-07BUY1,78031.59033.100 32.949USD 58,649 36.02
2025-03-31SELL-48232.26032.550 32.521USD -15,675 36.18 Profit of 1,763 on sale
2025-03-21SELL-48233.54035.240 35.070USD -16,904 36.36 Profit of 622 on sale
2025-03-12SELL-24332.69034.540 34.355USD -8,348 36.63 Profit of 552 on sale
2025-02-28SELL-24338.74038.930 38.911USD -9,455 36.64 Loss of -551 on sale
2025-02-25BUY24339.43039.930 39.880USD 9,691 36.51
2025-02-20SELL-24339.16039.640 39.592USD -9,621 36.38 Loss of -781 on sale
2025-02-19BUY48439.01039.180 39.163USD 18,955 36.33
2025-02-18BUY24238.22040.770 40.515USD 9,805 36.29
2024-12-30SELL-47230.25030.670 30.628USD -14,456 34.09 Profit of 1,636 on sale
2024-12-06SELL-24034.25034.790 34.736USD -8,337 34.10 Loss of -153 on sale
2024-12-04SELL-24036.31036.930 36.868USD -8,848 34.02 Loss of -684 on sale
2024-12-03SELL-48036.12037.040 36.948USD -17,735 33.94 Loss of -1,444 on sale
2024-11-21SELL-24235.68036.450 36.373USD -8,802 33.03 Loss of -808 on sale
2024-11-20SELL-24736.03036.280 36.255USD -8,955 32.87 Loss of -837 on sale
2024-11-19SELL-24736.34036.380 36.376USD -8,985 32.66 Loss of -918 on sale
2024-11-18SELL-96434.72036.000 35.872USD -34,581 32.53 Loss of -3,219 on sale
2024-11-12SELL-24136.63038.210 38.052USD -9,171 32.26 Loss of -1,396 on sale
2024-11-07SELL-24037.36037.770 37.729USD -9,055 31.47 Loss of -1,503 on sale
2024-11-05SELL-48035.47035.760 35.731USD -17,151 30.54 Loss of -2,489 on sale
2024-10-28SELL-24128.75029.460 29.389USD -7,083 28.53 Loss of -208 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of ATRC

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-1975,7640170,36544.5%
2025-09-1868,15017148,53945.9%
2025-09-1748,7910104,89846.5%
2025-09-16147,2710190,38077.4%
2025-09-15233,4780319,06673.2%
2025-09-12193,5940286,13867.7%
2025-09-11256,8970327,48978.4%
2025-09-10112,45530233,60948.1%
2025-09-09111,4310139,76479.7%
2025-09-0871,6260145,78049.1%
2025-09-0545,694089,38751.1%
2025-09-0452,064096,30154.1%
2025-09-03135,4330192,54570.3%
2025-09-02107,7591,850176,49561.1%
2025-08-2955,705095,37658.4%
2025-08-2858,317091,02464.1%
2025-08-2725,898058,26044.5%
2025-08-2675,1030101,68573.9%
2025-08-2599,5450129,03977.1%
2025-08-22156,3280201,03677.8%
2025-08-2160,501082,91873.0%
2025-08-2082,6380129,29863.9%
2025-08-19146,2350190,74176.7%
2025-08-18107,6950175,57661.3%
2025-08-1573,2770113,49464.6%
2025-08-14101,4890146,41769.3%
2025-08-1392,7780135,20568.6%
2025-08-1263,3612182,03034.8%
2025-08-11101,1051,225267,49737.8%
2025-08-0866,5840127,31152.3%
2025-08-07109,8390173,94763.1%
2025-08-06155,8470248,43962.7%
2025-08-05174,6010279,09962.6%
2025-08-04310,7590385,35280.6%
2025-08-01162,340600255,82163.5%
2025-07-31172,0730285,81760.2%
2025-07-30845,1852,5571,422,49559.4%
2025-07-29132,6080284,22946.7%
2025-07-28272,5800451,79960.3%
2025-07-25106,8983202,92652.7%
2025-07-2466,1690155,27042.6%
2025-07-23113,1250207,97854.4%
2025-07-2295,3070153,04762.3%
2025-07-2176,9310130,82658.8%
2025-07-1864,716097,34366.5%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.